HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Mathew Blurton-Jones Selected Research

C9orf72 Protein

1/2021C9orf72 deficiency promotes microglial-mediated synaptic loss in aging and amyloid accumulation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Mathew Blurton-Jones Research Topics

Disease

21Alzheimer Disease (Alzheimer's Disease)
01/2022 - 07/2004
9Neurodegenerative Diseases (Neurodegenerative Disease)
01/2022 - 11/2008
6Cognitive Dysfunction
01/2022 - 07/2004
5Dementia (Dementias)
05/2022 - 11/2015
5Inflammation (Inflammations)
05/2022 - 04/2009
5Synucleinopathies
01/2022 - 11/2015
4Parkinson Disease (Parkinson's Disease)
05/2022 - 01/2012
3Huntington Disease (Huntington's Disease)
01/2018 - 01/2017
3Neuroinflammatory Diseases
12/2017 - 03/2016
3Tauopathies
11/2017 - 01/2016
2Frontotemporal Dementia (Semantic Dementia)
01/2021 - 08/2013
2Amyloid Plaque
12/2019 - 02/2005
2Disease Progression
01/2017 - 07/2015
2Memory Disorders (Memory Loss)
01/2016 - 08/2009
1Hypersensitivity (Allergy)
01/2022
1Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease)
01/2021
1Edema (Dropsy)
01/2020
1Cerebral Amyloid Angiopathy (Congophilic Angiopathy)
01/2020
1Bites and Stings (Sting)
12/2017
1Neuroblastoma
11/2017
1Proteostasis Deficiencies
01/2016
1Inclusion Body Myopathy With Early-Onset Paget Disease And Frontotemporal Dementia
08/2013
1Osteitis Deformans (Paget's Disease of Bone)
08/2013
1Muscular Diseases (Myopathy)
08/2013
1Mitochondrial Diseases (Mitochondrial Disease)
08/2012
1Nervous System Diseases (Neurological Disorders)
07/2011

Drug/Important Bio-Agent (IBA)

10Proteins (Proteins, Gene)FDA Link
01/2022 - 08/2009
8Amyloid beta-PeptidesIBA
01/2021 - 07/2004
7Amyloid (Amyloid Fibrils)IBA
01/2022 - 08/2009
6SynucleinsIBA
05/2022 - 01/2012
4VaccinesIBA
01/2022 - 11/2017
3Brain-Derived Neurotrophic Factor (BDNF)IBA
01/2016 - 08/2009
3CaspasesIBA
02/2005 - 07/2004
2EpitopesIBA
01/2020 - 11/2017
2Peptides (Polypeptides)IBA
01/2020 - 01/2019
2DNA VaccinesIBA
01/2020 - 11/2017
2AntibodiesIBA
11/2017 - 11/2017
1B-Lymphocyte Epitopes (B-Cell Epitope)IBA
01/2022
1ProteomeIBA
01/2022
1Adenosine Diphosphate (ADP)IBA
01/2022
1RNA (Ribonucleic Acid)IBA
01/2021
1C9orf72 ProteinIBA
01/2021
1DipeptidesIBA
01/2021
1Mitochondrial DNA (mtDNA)IBA
12/2017
1Interferon Type IIBA
12/2017
1Ligases (Synthetase)IBA
12/2017
1DNA (Deoxyribonucleic Acid)IBA
11/2017
1Therapeutic UsesIBA
10/2017
1Monoclonal AntibodiesIBA
01/2017
1Dopamine (Intropin)FDA LinkGeneric
01/2017
1Glutamic Acid (Glutamate)FDA Link
01/2017
1CytokinesIBA
03/2016
1trkB ReceptorIBA
01/2016
1Cocaine (Cocaine HCl)IBA
01/2016
1Valosin Containing ProteinIBA
08/2013
1UbiquitinIBA
08/2013
1Proteasome Endopeptidase Complex (Proteasome)IBA
11/2012
1Indicators and Reagents (Reagents)IBA
07/2011
1Nerve Growth Factors (Neurotrophins)IBA
05/2011
1alpha-SynucleinIBA
05/2010
1PresenilinsIBA
08/2009
1Tumor Necrosis Factor InhibitorsIBA
04/2009
1Cell Cycle ProteinsIBA
01/2009
1Protein AggregatesIBA
11/2008

Therapy/Procedure

7Transplantation
01/2018 - 08/2009
3Therapeutics
10/2019 - 07/2004
2Immunotherapy
01/2020 - 01/2017
1Transcutaneous Electric Nerve Stimulation (TENS)
06/2017
1Investigational Therapies (Experimental Therapy)
07/2015